3/26
11:06 am
cort
Rating for CORT
Low
Report
Rating for CORT
3/26
10:15 am
cort
Rating for CORT
Low
Report
Rating for CORT
3/26
10:15 am
cort
Rating for CORT
Low
Report
Rating for CORT
3/26
09:00 am
cort
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
Medium
Report
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
3/26
09:00 am
cort
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
Medium
Report
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
3/26
08:45 am
cort
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
Low
Report
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
3/26
08:45 am
cort
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
Low
Report
Corcept Therapeutics upgraded to Peer Perform from Underperform at Wolfe Research
1/23
08:04 am
cort
Rating for CORT
Medium
Report
Rating for CORT
1/2
08:05 am
cort
Rating for CORT
Medium
Report
Rating for CORT
1/2
07:18 am
cort
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/31
10:00 am
cort
Corcept Therapeutics (NASDAQ:CORT) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $30.00 price target on the stock.
Medium
Report
Corcept Therapeutics (NASDAQ:CORT) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $30.00 price target on the stock.
12/31
10:00 am
cort
Corcept Therapeutics (NASDAQ:CORT) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $30.00 price target on the stock.
Medium
Report
Corcept Therapeutics (NASDAQ:CORT) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $30.00 price target on the stock.
12/31
09:47 am
cort
Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
Medium
Report
Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
12/31
09:47 am
cort
Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
Medium
Report
Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research